Somasundaram et al. (2017) [55] observed that in rats with melanoma, tumor infiltration of mast cells was related to resistance to anti-PD-1 therapy, which raises a new question: could one of the mechanisms of chemoresistance to the treatments already developed for high-grade MCTs be related to high checkpoint expression? Here, PDCD1 is linked to melanoma.